Brief: Abvc Biopharma Provides Updates On Adhd Phase Iib Clinical Study

ABVC Biopharma

23/08/2023 13:32

Aug 23 (Reuters) - 
  
    * ABVC BIOPHARMA PROVIDES UPDATES ON ADHD PHASE IIB CLINICAL
STUDY
    * ABVC BIOPHARMA INC - FOR VITARGUS, CO INTENDS TO CONDUCT
GLOBAL
CLINICAL TRIALS THROUGH PHASE III
    * ABVC BIOPHARMA INC - 60 SUBJECTS HAD BEEN ENROLLED AND 53
HAD
COMPLETED EIGHT-WEEK STUDY FOR CO'S ADHD PHASE IIB CLINICAL
STUDY
    * ABVC BIOPHARMA INC - PHASE IIB CLINICAL STUDY CONTINUES
PHASE
IIA CLINICAL STUDY OF ABV-1505

Source text for Eikon:  ID:nGNX1TYLrn 
Further company coverage:  ABVC.O 

 ((reuters.briefs@thomsonreuters.com;))